Cytokinetics
Ajay Chawla is a highly accomplished professional in the field of translational sciences, currently serving as Vice President at Cytokinetics since June 2023, where oversight of teams focuses on innovation in Cardiovascular and Neuromuscular Diseases. Previously, Ajay held the position of Vice President of Discovery Biology for Cardiometabolic Disease at Merck from January 2019 to May 2023, leading a substantial research team in drug discovery efforts for multiple health conditions. Academic credentials include a progression from Assistant Professor to Professor of Physiology and Medicine at the University of California, San Francisco, alongside a foundational role at Stanford University School of Medicine. Ajay's education encompasses a Doctor of Medicine and a Doctor of Philosophy in Physiology from the University of Pennsylvania, complemented by a Bachelor of Science in Biomedical Engineering from Johns Hopkins University.
Cytokinetics
15 followers
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators as potential treatments for people with diseases characterized by impaired or declining muscle function.